+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Antacid Market Report and Forecast 2025-2034

  • PDF Icon

    Report

  • 400 Pages
  • June 2025
  • Region: Global
  • Expert Market Research
  • ID: 6102892
The global antacid market was valued at USD 7.02 Billion in 2024, driven by the rising prevalence of gastroesophageal reflux disease and other acid-related disorders across the globe. The market is anticipated to grow at a CAGR of 3.20% during the forecast period of 2025-2034, with the values likely to reach USD 9.62 Billion by 2034.

Antacid Market Overview

Antacids are commonly utilized medications that counteract excessive stomach acid, offering relief from heartburn, indigestion, and acid reflux. These are accessible without a prescription in different forms like tablets and liquids, providing rapid and effective relief from symptoms. The market is driven by advancements in formulations, changing consumer health trends, and heightened awareness of digestive wellness. The increasing occurrence of acid-related issues, combined with progress in medical research and regulatory backing, fuels the ongoing expansion of the antacids market, improving the quality of life for numerous individuals.

Antacid Market Growth Drivers

Rising Prevalence of Gastroesophageal Reflux Disease To Boost Market Growth

The growing prevalence of gastroesophageal reflux disease, affecting around 30% of individuals in Western societies, significantly contributes to the expansion of the global antacid market. With gastroesophageal reflux disease being one of the most common disorders in primary care, the demand for effective antacid medications has surged. The increasing incidence of gastroesophageal reflux disease-related symptoms such as heartburn and regurgitation, alongside complications like esophageal injury, drives both preventive and symptomatic treatments, fueling market growth.

Antacid Market Trends

The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:

Rising Demand for Over-the-Counter Antacids

The market is witnessing a substantial increase in the demand for over-the-counter products. Consumers are progressively choosing over-the-counter antacids to handle typical symptoms of acid reflux and heartburn. The increasing inclination towards self-medication is propelling the growth of over-the-counter antacids in both advanced and developing markets.

Shift Towards Natural and Herbal Antacids

The market is witnessing a noticeable shift towards natural and herbal antacid formulations. With rising health consciousness, consumers are seeking alternatives to synthetic drugs, driving demand for antacids that incorporate organic ingredients such as ginger, chamomile, or licorice root. This trend highlights a growing preference for products that align with holistic health and wellness trends, offering gentle yet effective relief from acidity without chemical additives.

Integrating New Delivery Systems

The market is transforming with the incorporation of innovative delivery methods, like chewable tablets. These advancements meet consumer desires for simplicity and user-friendliness. Chewable forms offer quicker relief and enhanced portability, attracting people especially those in need of on-the-move options. The movement towards more accessible and creative product designs is facilitating market expansion, broadening the consumer audience for antacid items.

Increasing Awareness About Digestive Health

There is a significant increase in awareness regarding digestive health. There is a rising number of consumers focusing on their gut health and understanding the significance of addressing issues such as acid reflux and indigestion, which will increase the need for antacids. Moreover, health initiatives and educational campaigns are enhancing consumer awareness, encouraging a move towards preventive care, and driving up sales of antacid products as part of daily wellness practices.

Antacid Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Dosage Form

  • Tablet
  • Capsule
  • Suspension
  • Others

Market Breakup by Application

  • Gastroesophageal Reflux Disease
  • Heartburn
  • Indigestion
  • Others

Market Breakup by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Antacid Market Share

Segmentation Based on Distribution Channel to Witness Substantial Growth

The distribution channel segment is divided into hospital pharmacies, retail pharmacies, and others. Retail pharmacies are anticipated to dominate the market share throughout the forecast period. Their ease of use, convenient locations, long operating hours, and rapid services contribute to their increasing popularity. Retail pharmacies provide a variety of medications, effective order processing systems, and tailored consultations with pharmacists, improving the overall customer experience. These elements play a crucial role in their market leadership, establishing retail pharmacies as a favored option for customers.

Antacid Market Analysis by Region

The market is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the market share because of a significant prevalence of gastrointestinal issues such as acid reflux and GERD, attributed to stress, unhealthy eating habits, and obesity. These lifestyle patterns drive the need for antacids as a quick way to relieve symptoms. On the other hand, the Asia Pacific region is projected to witness the fastest growth, as urbanization, shifting diets, heightened stress, and improved healthcare access augment the need for antacids, especially with the growing middle class and better affordability of over-the-counter products.

Leading Players in the Antacid Market

The key features of the market report comprise patent analysis, clinical trial analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Bayer AG

Bayer AG, a prominent global company in pharmaceuticals and biotechnology, boosted its presence in the antacid market through well-known brands such as Rennie and Alka-Seltzer. Alka-Seltzer is widely recognized for relieving digestive issues and associated pain.

Haleon plc

Haleon plc, a prominent British multinational consumer healthcare firm located in Weybridge, England, is a major player in the global antacid market. Through reliable brands such as Eno and Tums, Haleon meets the increasing consumer demand for efficient digestive health solutions, promoting market growth via innovation and a robust global footprint.

Sun Pharmaceutical Industries Limited

Sun Pharma, a global leader in generic medications, propels market expansion through its vast product development and manufacturing expertise in complex formulations, active pharmaceutical ingredients, and over-the-counter offerings. Its cutting-edge digestive care products, such as pepmelt mouth-melt granules, pepfiz effervescent tablets, and pepfiz antacid powder, have broadened its reach in the global antacid market, addressing various consumer needs.

Procter & Gamble

Procter & Gamble, a global healthcare leader, drives market growth through innovative products and strategic collaborations. A key player in the antacid market with its Rolaids brand, P&G expanded its reach in March 2024 by partnering with Lil' Drug Store Products to target heartburn sufferers. P&G's tactical investments in advertising, product improvements, and distribution strengthen Rolaids' competitive stance.

Other key players in the market include Sanofi, WellSpring Pharmaceutical Corporation, Advance Pharmaceutical Inc., Reckitt Benckiser Group PLC, Teva Pharmaceuticals Industries Ltd., and Lupin.

Key Questions Answered in the Antacid Market Report

  • What was the antacid market value in 2024?
  • What is the antacid market forecast outlook for 2025-2034?
  • What are the regional markets covered in the report?
  • What is the market segmentation based on dosage form?
  • What is the market segmentation based on application?
  • What is the market breakup based on the distribution channel?
  • What major factors aid the demand for the antacid market?
  • How has the market performed so far and how is it anticipated to perform in the coming years?
  • What are the major drivers, opportunities, and restraints in the market?
  • What are the major trends influencing the market?
  • Which regional market is expected to dominate the market share in the forecast period?
  • Which country is likely to experience elevated growth during the forecast period?
  • Who are the key players involved in the antacid market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Antacid Market Overview
3.1 Global Antacid Market Historical Value (2018-2024)
3.2 Global Antacid Market Forecast Value (2025-2034)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Antacid Market Landscape*
5.1 Global Antacid Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Antacid Market: Product Landscape
5.2.1 Analysis by Dosage Form
5.2.2 Analysis by Application
6 Global Antacid Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Antacid Market Segmentation (218-2034)
7.1 Global Antacid Market (2018-2034) by Dosage Form
7.1.1 Market Overview
7.1.2 Tablet
7.1.3 Capsule
7.1.4 Suspension
7.1.5 Others
7.2 Global Antacid Market (2018-2034) by Application
7.2.1 Market Overview
7.2.2 Gastroesophageal Reflux Disease
7.2.3 Heartburn
7.2.4 Indigestion
7.2.5 Others
7.3 Global Antacid Market (2018-2034) by Distribution Channel
7.3.1 Market Overview
7.3.2 Hospital Pharmacies
7.3.3 Retail Pharmacies
7.3.4 Others
7.4 Global Antacid Market (2018-2034) by Region
7.4.1 Market Overview
7.4.2 North America
7.4.3 Europe
7.4.4 Asia Pacific
7.4.5 Latin America
7.4.6 Middle East and Africa
8 North America Antacid Market (218-2034)
8.1 North America Antacid Market (2018-2034) by Dosage Form
8.1.1 Market Overview
8.1.2 Tablet
8.1.3 Capsule
8.1.4 Suspension
8.1.5 Others
8.2 North America Antacid Market (2018-2034) by Application
8.2.1 Market Overview
8.2.2 Gastroesophageal Reflux Disease
8.2.3 Heartburn
8.2.4 Indigestion
8.2.5 Others
8.3 North America Antacid Market (2018-2034) by Distribution Channel
8.3.1 Market Overview
8.3.2 Hospital Pharmacies
8.3.3 Retail Pharmacies
8.3.4 Others
8.4 North America Antacid Market (2018-2034) by Country
8.4.1 United States of America
8.4.2 Canada
9 Europe Antacid Market (218-2034)
9.1 Europe Antacid Market (2018-2034) by Dosage Form
9.1.1 Market Overview
9.1.2 Tablet
9.1.3 Capsule
9.1.4 Suspension
9.1.5 Others
9.2 Europe Antacid Market (2018-2034) by Application
9.2.1 Market Overview
9.2.2 Gastroesophageal Reflux Disease
9.2.3 Heartburn
9.2.4 Indigestion
9.2.5 Others
9.3 Europe Antacid Market (2018-2034) by Distribution Channel
9.3.1 Market Overview
9.3.2 Hospital Pharmacies
9.3.3 Retail Pharmacies
9.3.4 Others
9.4 Europe Antacid Market (2018-2034) by Country
9.4.1 United Kingdom
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Others
10 Asia Pacific Antacid Market (218-2034)
10.1 Asia Pacific Antacid Market (2018-2034) by Dosage Form
10.1.1 Market Overview
10.1.2 Tablet
10.1.3 Capsule
10.1.4 Suspension
10.1.5 Others
10.2 Asia Pacific Antacid Market (2018-2034) by Application
10.2.1 Market Overview
10.2.2 Gastroesophageal Reflux Disease
10.2.3 Heartburn
10.2.4 Indigestion
10.2.5 Others
10.3 Asia Pacific Antacid Market (2018-2034) by Distribution Channel
10.3.1 Market Overview
10.3.2 Hospital Pharmacies
10.3.3 Retail Pharmacies
10.3.4 Others
10.4 Asia Pacific Antacid Market (2018-2034) by Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 ASEAN
10.4.5 Australia
10.4.6 Others
11 Latin America Antacid Market (218-2034)
11.1 Latin America Antacid Market (2018-2034) by Dosage Form
11.1.1 Market Overview
11.1.2 Tablet
11.1.3 Capsule
11.1.4 Suspension
11.1.5 Others
11.2 Latin America Antacid Market (2018-2034) by Application
11.2.1 Market Overview
11.2.2 Gastroesophageal Reflux Disease
11.2.3 Heartburn
11.2.4 Indigestion
11.2.5 Others
11.3 Latin America Antacid Market (2018-2034) by Distribution Channel
11.3.1 Market Overview
11.3.2 Hospital Pharmacies
11.3.3 Retail Pharmacies
11.3.4 Others
11.4 Latin America Antacid Market (2018-2034) by Country
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Mexico
11.4.4 Others
12 Middle East and Africa Antacid Market (218-2034)
12.1 Middle East and Africa Antacid Market (2018-2034) by Dosage Form
12.1.1 Market Overview
12.1.2 Tablet
12.1.3 Capsule
12.1.4 Suspension
12.1.5 Others
12.2 Middle East and Africa Antacid Market (2018-2034) by Application
12.2.1 Market Overview
12.2.2 Gastroesophageal Reflux Disease
12.2.3 Heartburn
12.2.4 Indigestion
12.2.5 Others
12.3 Middle East and Africa Antacid Market (2018-2034) by Distribution Channel
12.3.1 Market Overview
12.3.2 Hospital Pharmacies
12.3.3 Retail Pharmacies
12.3.4 Others
12.4 Middle East and Africa Antacid Market (2018-2034) by Country
12.4.1 Saudi Arabia
12.4.2 United Arab Emirates
12.4.3 Nigeria
12.4.4 South Africa
12.4.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
14 Clinical Trials Analysis
14.1 Analysis by Trial Registration Year
14.2 Analysis by Trial Status
14.3 Analysis by Trial Phase
14.4 Analysis by Therapeutic Area
14.5 Analysis by Geography
15 Grants Analysis
15.1 Analysis by Year
15.2 Analysis by Amount Awarded
15.3 Analysis by Issuing Authority
15.4 Analysis by Grant Application
15.5 Analysis by Funding Institute
15.6 Analysis by NIH Departments
15.7 Analysis by Recipient Organization
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Drug Class of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Strategic Initiatives
17.1 Analysis by Partnership Instances
17.2 Analysis by Drug Class of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Market Share Analysis, By Region (Top 5 Companies)
18.1.1 Market Share Analysis: Global
18.1.2 Market Share Analysis: North America
18.1.3 Market Share Analysis: Europe
18.1.4 Market Share Analysis: Asia Pacific
18.1.5 Market Share Analysis: Others
18.2 Bayer AG
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Company News and Development
18.2.5 Certifications
18.3 Haleon plc
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Company News and Development
18.3.5 Certifications
18.4 Sun Pharmaceutical Industries Limited
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Company News and Development
18.4.5 Certifications
18.5 Sanofi
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Company News and Development
18.5.5 Certifications
18.6 WellSpring Pharmaceutical Corporation
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Company News and Development
18.6.5 Certifications
18.7 Advance Pharmaceutical Inc.
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Company News and Development
18.7.5 Certifications
18.8 Reckitt Benckiser Group PLC
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Company News and Development
18.8.5 Certifications
18.9 Procter & Gamble
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Company News and Development
18.9.5 Certifications
18.10 Teva Pharmaceuticals Industries Ltd.
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Company News and Development
18.10.5 Certifications
18.11 Lupin
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Company News and Development
18.11.5 Certifications
19 Global Antacid Market - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)

Companies Mentioned

  • Bayer AG
  • Haleon plc
  • Sun Pharmaceutical Industries Limited
  • Procter & Gamble

Table Information